Back
Akero Therapeutics Vs. Lemonade Industry Stock Comparison
Sell
28
AKRO
Akero Therapeutics
Last Price:
$28.26
Seasonality Move:
-12.57%
Sell
50
LMND
Lemonade
Last Price:
$39.44
Seasonality Move:
-23.03%
Sell
28
Akero Therapeutics (AKRO)
is a Sell
Is Akero Therapeutics a Buy, Sell or Hold?
-
The current Akero Therapeutics [AKRO] share price is $28.25. The Score for AKRO is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
-
AKRO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Lemonade (LMND)
is a Sell
Is Lemonade a Buy, Sell or Hold?
-
LMND is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $28.25Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AKRO is experiencing slight buying pressure.
LMND Stock Price Chart
AKRO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.65 | Sell |
Relative Strength Index (14 RSI): | 41.96 | Sell |
Chaikin Money Flow: | 0 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (28.88 - 31.6) | Sell |
Bollinger Bands (100): | (26.3 - 31.34) | Sell |
LMND Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.88 | Buy |
Relative Strength Index (14 RSI): | 47.98 | Sell |
Chaikin Money Flow: | -2463958 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (40.55 - 48.49) | Sell |
Bollinger Bands (100): | (14.38 - 38.26) | Buy |
AKRO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 28.9 | Sell |
20-day SMA: | 29.85 | Sell |
50-day SMA: | 30.72 | Sell |
200-day SMA: | 25.89 | Buy |
8-day EMA: | 28.85 | Sell |
20-day EMA: | 29.58 | Sell |
50-day EMA: | 29.85 | Sell |
200-day EMA: | 27.85 | Buy |
LMND Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 40.82 | Sell |
20-day SMA: | 43.16 | Sell |
50-day SMA: | 35.31 | Buy |
200-day SMA: | 21.86 | Buy |
8-day EMA: | 41.27 | Sell |
20-day EMA: | 41.44 | Sell |
50-day EMA: | 36.48 | Buy |
200-day EMA: | 24.88 | Buy |
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.08 per share, and a decrease next year of $0.90 per share.
Lemonade Earnings Growth & LMND Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.17 per share, and an increase next year of $0.29 per share.
Akero Therapeutics Technical Analysis
Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Lemonade Technical Analysis
Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |